만성질환 관리 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Chronic Disease Management Market was valued at USD 6.2 billion in 2024 and is estimated to grow at a CAGR of 11.7% to reach USD 18.8 billion by 2034, driven by the increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and hypertension, which necessitate effective management strategies. Additionally, advancements in digital health technologies, including telehealth services, remote monitoring devices, and electronic health records, have transformed the landscape of chronic care. These technological advancements not only enhance care coordination and clinical decision-making but also support proactive interventions that prevent disease progression, minimize hospital readmissions, and increase treatment adherence, ultimately transforming chronic care delivery and boosting system-wide efficiency.

Additionally, they empower healthcare providers with real-time data insights, streamline communication between patients and care teams, and facilitate timely medication adjustments, all of which contribute to more responsive, patient-centered care and long-term health management. These tools also foster greater patient engagement by promoting self-monitoring, education, and accountability, which are essential for managing complex, long-duration conditions effectively.

The cardiovascular diseases segment was valued at USD 2.2 billion in 2024 and is anticipated to reach USD 6.3 billion by 2034. The rising incidence of conditions like coronary artery disease, heart failure, and hypertension has increased the demand for comprehensive management solutions. Telehealth platforms, wearable devices, and remote monitoring systems help in tracking vital signs such as blood pressure and heart rate, facilitating timely interventions, and enhancing patient compliance with treatment regimens.

In 2024, the providers segment dominated the market, accounting for 53.8% of the share, and is expected to grow at a CAGR of 11.5% from 2025 to 2034. Healthcare providers, including hospitals, clinics, and specialized care centers, are central to chronic disease management services. Integrating digital health technologies allows providers to offer continuous care, monitor patient progress, and adjust treatment plans as needed, leading to improved patient outcomes and satisfaction.

U.S. Chronic Disease Management Market accounted for USD 2.2 billion in 2024 and is projected to grow at a CAGR of 11.1% between 2025 and 2034. The country's advanced healthcare infrastructure, widespread adoption of digital health technologies, and supportive reimbursement policies contribute to this growth. The increasing prevalence of chronic conditions among the U.S. population further drives the demand for effective management solutions.

Key players in the Global Chronic Disease Management Market include ResMed, Veradigm, IBM Corporation, Amwell, Oracle Corporation, Teladoc Health, Cerner Corporation, HealthSnap, Medtronic, and Koninklijke Philips N.V. These companies are focusing on developing innovative solutions to enhance chronic disease management. Strategies such as expanding telehealth services, integrating artificial intelligence for predictive analytics, and forming partnerships with healthcare providers are being employed to strengthen their market presence. Additionally, investments in research and development aim to improve patient engagement and treatment outcomes, positioning these companies for sustained growth in the evolving healthcare landscape.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease
    • 3.2.1.2 Growing advancements in telehealth and remote monitoring
    • 3.2.1.3 Expanding digital health sector
    • 3.2.1.4 Government initiatives and funding for innovative solution
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High implementation costs
    • 3.2.2.2 Data privacy and security concerns
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Retaliatory measures
  • 3.5.2 Impact on the Industry
    • 3.5.2.1 Supply-side impact (raw materials)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (selling price)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiovascular diseases (CVD)
• 5.3 Diabetes
• 5.4 Chronic respiratory pulmonary diseases (COPD)
• 5.5 Cancer
• 5.6 Neurological disorders
• 5.7 Other disease types

Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Solutions
  • 6.2.1 Web-based solutions
  • 6.2.2 Cloud-based solutions
  • 6.2.3 On-premises solutions
• 6.3 Services
  • 6.3.1 Disease management program and services
  • 6.3.2 Monitoring services
  • 6.3.3 Counseling and support services
  • 6.3.4 Other service types

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Providers
• 7.3 Payers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Active Health Technologies
• 9.2 Amwell
• 9.3 Apollo TeleHealth
• 9.4 Epic Systems
• 9.5 HealthSnap
• 9.6 IBM
• 9.7 Koninklijke Philips N.V.
• 9.8 Medicross
• 9.9 Medtronic
• 9.10 Oracle
• 9.11 ResMed
• 9.12 ScienceSoft USA
• 9.13 Teladoc
• 9.14 TimeDoc Health
• 9.15 Topcon Healthcare
• 9.16 Veradigm
• 9.17 ZEISS